MedTrace Logo

Validation of New Prognostic Biomarkers in Patients With Decompensated Cirrhosis

NCT06855056 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 189

Last updated 2025-08-06

No results posted yet for this study

Summary

The study aims to test the effectiveness of new biomarkers (measurable molecules in our body) in predicting the health outcome of patients with liver cirrhosis discharged from the hospital after a serious complication of the disease

Conditions

Sponsors & Collaborators

  • Universität Münster

    collaborator OTHER

  • IRCCS Azienda Ospedaliero-Universitaria di Bologna

    collaborator OTHER

  • Hospital Universitari Vall d'Hebron Research Institute

    collaborator OTHER

  • Hospital Clinic de Barcelona, Barcelona, Spain

    collaborator UNKNOWN

  • Hospital Universitario Ramon y Cajal

    collaborator OTHER

  • Beaujon Hospital

    collaborator OTHER

  • University Hospital, Aachen

    collaborator OTHER

  • A.O.U. Città della Salute e della Scienza

    collaborator OTHER

  • European Foundation for Study of Chronic Liver Failure

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-03-01
Primary Completion
2026-03-30
Completion
2026-09-30

Countries

  • France
  • Germany
  • Italy
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06855056 on ClinicalTrials.gov